ketamine has been researched along with Metabolic Syndrome in 1 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with ketamine, a non-competitive glutamate N-methyl-d-aspartic acid (NMDA) receptor antagonist, is known to have paradoxical effects of neuroprotection and neurotoxicity." | 1.34 | The expression of Troponin T1 gene is induced by ketamine in adult mouse brain. ( Lowe, XR; Lu, X; Marchetti, F; Wyrobek, AJ, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lowe, XR | 1 |
Lu, X | 1 |
Marchetti, F | 1 |
Wyrobek, AJ | 1 |
1 other study available for ketamine and Metabolic Syndrome
Article | Year |
---|---|
The expression of Troponin T1 gene is induced by ketamine in adult mouse brain.
Topics: Age Factors; Animals; Behavior, Animal; Brain; Brain Diseases; Disease Models, Animal; Excitatory Am | 2007 |